Cargando…
How to Select Patients for Left Ventricular Assist Devices? A Guide for Clinical Practice
In recent years, a significant improvement in left ventricular assist device (LVAD) technology has occurred, and the continuous-flow devices currently used can last more than 10 years in a patient. Current studies report that the 5-year survival rate after LVAD implantation approaches that after a h...
Autores principales: | Masarone, Daniele, Houston, Brian, Falco, Luigi, Martucci, Maria L., Catapano, Dario, Valente, Fabio, Gravino, Rita, Contaldi, Carla, Petraio, Andrea, De Feo, Marisa, Tedford, Ryan J., Pacileo, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455625/ https://www.ncbi.nlm.nih.gov/pubmed/37629257 http://dx.doi.org/10.3390/jcm12165216 |
Ejemplares similares
-
Vericiguat: The Fifth Harmony of Heart Failure with Reduced Ejection Fraction
por: Falco, Luigi, et al.
Publicado: (2023) -
Left Ventricular Assist Device Implantation in a Thrombosed Apical Aneurysm
por: Masarone, Daniele, et al.
Publicado: (2021) -
The ABC of Heart Transplantation—Part 1: Indication, Eligibility, Donor Selection, and Surgical Technique
por: Masarone, Daniele, et al.
Publicado: (2023) -
The Role of Echocardiography in the Management of Heart Transplant Recipients
por: Masarone, Daniele, et al.
Publicado: (2021) -
Levosimendan as a “Bridge to Optimization” in Patients with Advanced Heart Failure with Reduced Ejection—A Single-Center Study
por: Masarone, Daniele, et al.
Publicado: (2022)